A Penn-founded biotech company that helps scientists test drugs and therapeutics has raised $4 million in order to more widely adopt their platform that embraces “organs on chip” technology. Vivodyne'
Strong investor interest in local life sciences companies continued during the first quarter of 2021 with 16 Philadelphia-area businesses reeling in more than $2.9 billion.
Carisma Therapeutics Inc. raised a Series B equity financing this year bringing the total amount raised in this round to $59 million and CARISMA's total capital raised to date to nearly $121 million.
Penn was picked as one of 16 universities to receive part of $75 million in funding for a five-year artificial intelligence research program from the Toyota Research Institute.